Company / R&D per Share
Neurogene Inc. R&D per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$4.10
FY2025
5-year range
$1.21 / $4.10
FY2021-FY2025
Trend
+18.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $1.21 to $4.10 over the past 7 years.
Based on SEC 10-K filings.
4.10 in FY2025.
Improved from $1.21 to $4.10 over the past 7 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 18.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.24 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.10 | +18.5% |
| FY2024 | $3.46 | - |
| FY2019 | - | - |
| FY2018 | $1.21 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026